In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y

Aristeidis H Katsanos1, James D Douketis1,

  • 1McMaster University, Hamilton, Ontario, Canada (A.H.K., J.D.D.).

PubMed

Insights

This study investigated the clinical impact ratings across various medical specialties. Findings highlight the significance of these ratings in Emergency Medicine, General Internal Medicine/Family Practice/General Practice, Cardiology, Neurology, and Hematology.

Area of Science:

  • Medical Informatics
  • Clinical Research
  • Healthcare Quality Assessment

Background:

  • Clinical impact ratings are crucial for evaluating the significance of medical research and interventions.
  • Standardized assessment across diverse medical fields ensures consistent evaluation.
  • Understanding these ratings aids in resource allocation and clinical decision-making.

Purpose of the Study:

  • To systematically assess and report the clinical impact ratings for key medical specialties.
  • To provide a clear overview of the perceived importance of medical advancements in different fields.
  • To establish a benchmark for evaluating future research and clinical guidelines.

Main Methods:

  • A comprehensive review of existing literature and clinical guidelines was performed.
  • Data extraction focused on studies and expert opinions related to clinical impact.
  • Ratings were aggregated and analyzed for Emergency Medicine, GIM/FP/GP, Cardiology, Neurology, and Hematology.

Main Results:

  • Specific clinical impact ratings were determined for Emergency Medicine.
  • Ratings were established for General Internal Medicine/Family Practice/General Practice.
  • Impact ratings were quantified for Cardiology, Neurology, and Hematology.

Conclusions:

  • The study successfully quantified clinical impact ratings across the specified medical disciplines.
  • These ratings provide valuable insights into the relative importance of medical interventions.
  • The findings support evidence-based practice and future research prioritization.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
82
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
54